Sanofi-Aventis signs drug with potential to reverse diabetes

April 9, 2010
Research and Development Sanofi, diabetes

Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …

EAASMMikeIsles

Mike Isles joins EAASM

April 9, 2010
Manufacturing and Production EAASM, appointment, manufacturing and production, supply chain

The European Alliance for Access to Safe Medicines (EAASM) has appointed Mike Isles executive director. He was most recently at …

Genentech opens $400m fill-and-finish plant

April 8, 2010
Manufacturing and Production Genentech

US biotech giant Genentech has officially opened its new 296,000 sq. ft. biologics manufacturing facility in Hillsboro, near Portland, Oregon. …

AstraZeneca dodges another Seroquel lawsuit

April 8, 2010
Sales and Marketing AZ, Seroquel, US

AstraZeneca has defeated another US lawsuit seeking compensation for diabetes side-effects allegedly caused by its drug Seroquel. A US Federal …

Talking Point: Humour and healthcare advertising

April 8, 2010
Medical Communications Pulsar, Talking Point, medical communications

It will come as no surprise when I say that humour in healthcare advertising is a rare occurrence. So why …

EdelmanKajsaWilhelmsson

Edelman appoints Kajsa Wilhelmsson

April 8, 2010
Medical Communications Edelman, appointment, medical communications

Kajsa Wilhelmsson has joined Edelman’s health practice as director of European health public affairs. She will be based in the …

ICON and Tigermed forge China alliance

April 7, 2010
Research and Development CRO, China, ICON

Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …

GSK pandemrix

UK recoups cost from unused H1N1 vaccine

April 7, 2010
Sales and Marketing GSK, NHS, h1n1

The UK government has agreed a deal with GlaxoSmithKine on surplus supplies of its H1N1 vaccine Pandemrix. The Department of …

Solvay reprimanded for cheques to GPs

April 7, 2010
Sales and Marketing Code of Practice, PMCPA, Solvay

Three UK pharma companies have been ‘named and shamed’ for serious breaches of the ABPI’s Code of Practice. Solvay, Pfizer …

Sigma-Aldrich opens large-scale high-potency unit

April 7, 2010
Manufacturing and Production Sigma-Aldrich

Sigma-Aldrich has increased its high-potency active pharmaceutical ingredient (HPAPI) production capacity with the opening of a newly-expanded facility that is …

GSK and Crucell to develop malaria vaccine

April 7, 2010
Sales and Marketing Crucell, GSK, malaria

GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …

RochePitzer

Frank Pitzer made chief executive at NimbleGen

April 7, 2010
Research and Development NimbleGen, Roche, appointment, research and development

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …

New consultancy Strategic North launched

April 7, 2010
Medical Communications, Sales and Marketing Consultancy, coleiro, marketing, marketing ideas, strategy

A new healthcare industry marketing consultancy based in the North West of England has been launched. Strategic North is a …

Publicis acquires In-Sync

April 6, 2010
Medical Communications agency, medical communications, publicis

Global communications group Publicis has acquired Toronto-based In-Sync, a company specialising in healthcare market research. In-Sync will become part of …

Manufacturing news in brief

April 6, 2010
Manufacturing and Production NIB, Valeant, Warner Chilcott, baxter

 This week’s round-up of recent developments in the pharmaceutical manufacturing arena sees a new facility build for Ireland’s HKPB and …

Cameron talks to cancer patient

Conservative claims on cancer drugs disputed

April 6, 2010
Sales and Marketing NHS, NICE, election

A think tank has disputed Conservative claims that funds can be diverted to pay for greater access to new cancer …

Warner Chilcott gets Actonel lift

April 6, 2010
Sales and Marketing Sanofi, Warner Chilcott, actonel, osteoporosis

Warner Chilcott has assumed all commercial responsibility for its osteoporosis drug Actonel in the US. Sanofi-Aventis has agreed to pass …

Talking Point: Responding to Trial Emergencies

April 6, 2010
Research and Development

Unblinding is only done when it is deemed essential for the patients by the subject’s physician or a regulatory body, …

retacrit

Biosimilars: the great balancing act

April 6, 2010
Research and Development biogenerics, biosimilars

Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …

SirJamesBlack

Obituary: Sir James Black

April 6, 2010
Research and Development appointment, research and development

Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …

The Gateway to Local Adoption Series

Latest content